Paloma Partners’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,140
| Closed | -$394K | – | 124 |
|
|
2025
Q1 | $394K | Buy |
+1,140
| New | +$367K | 0.05% | 99 |
|
|
2024
Q4 | – | Sell |
-1,060
| Closed | -$431K | – | 619 |
|
|
2024
Q3 | $431K | Sell |
1,060
-5,580
| -84% | -$2.04M | 0.01% | 672 |
|
|
2024
Q2 | $2.13M | Buy |
6,640
+5,279
| +388% | +$1.72M | 0.06% | 332 |
|
|
2024
Q1 | $454K | Buy |
1,361
+1,279
| +1,560% | +$391K | 0.02% | 432 |
|
|
2023
Q4 | $22.2K | Buy |
+82
| New | +$20.3K | ﹤0.01% | 686 |
|
|
2023
Q3 | – | Sell |
-1,307
| Closed | -$397K | – | 796 |
|
|
2023
Q2 | $397K | Buy |
+1,307
| New | +$363K | 0.01% | 511 |
|
|
2022
Q4 | – | Sell |
-1,841
| Closed | -$338K | – | 1023 |
|
|
2022
Q3 | $338K | Sell |
1,841
-25,559
| -93% | -$5.09M | 0.02% | 595 |
|
|
2022
Q2 | $4.61M | Buy |
27,400
+23,128
| +541% | +$4.97M | 0.16% | 118 |
|
|
2022
Q1 | $1.07M | Sell |
4,272
-1,887
| -31% | -$474K | 0.03% | 414 |
|
|
2021
Q4 | $1.58M | Sell |
6,159
-49,998
| -89% | -$12.2M | 0.02% | 525 |
|
|
2021
Q3 | $13.6M | Buy |
56,157
+52,162
| +1,306% | +$12.8M | 0.33% | 37 |
|
|
2021
Q2 | $826K | Sell |
3,995
-25,635
| -87% | -$5.22M | 0.01% | 737 |
|
|
2021
Q1 | $5.58M | Buy |
29,630
+26,284
| +786% | +$4.63M | 0.12% | 138 |
|
|
2020
Q4 | $551K | Buy |
3,346
+3,165
| +1,749% | +$463K | 0.01% | 857 |
|
|
2020
Q3 | $23K | Sell |
181
-42,920
| -100% | -$5.31M | ﹤0.01% | 2001 |
|
|
2020
Q2 | $4.18M | Buy |
43,101
+34,921
| +427% | +$3.63M | 0.07% | 358 |
|
|
2020
Q1 | $735K | Sell |
8,180
-18,267
| -69% | -$2.37M | 0.04% | 377 |
|
|
2019
Q4 | $3.91M | Sell |
26,447
-617
| -2% | -$82.9K | 0.06% | 317 |
|
|
2019
Q3 | $3.26M | Buy |
27,064
+9,922
| +58% | +$1.28M | 0.07% | 249 |
|
|
2019
Q2 | $2.32M | Buy |
17,142
+11,942
| +230% | +$1.51M | 0.04% | 367 |
|
|
2019
Q1 | $678K | Buy |
+5,200
| New | +$698K | 0.02% | 922 |
|
|
2018
Q4 | – | Sell |
-64,900
| Closed | -$9.03M | – | 1474 |
|
|
2018
Q3 | $9.03M | Buy |
64,900
+40,050
| +161% | +$4.99M | 0.16% | 87 |
|
|
2018
Q2 | $2.55M | Sell |
24,850
-15,906
| -39% | -$1.61M | 0.05% | 361 |
|
|
2018
Q1 | $3.95M | Sell |
40,756
-1,752
| -4% | -$170K | 0.06% | 268 |
|
|
2017
Q4 | $3.73M | Buy |
42,508
+34,636
| +440% | +$2.78M | 0.05% | 381 |
|
|
2017
Q3 | $626K | Sell |
7,872
-17,342
| -69% | -$1.39M | 0.01% | 1418 |
|
|
2017
Q2 | $2.2M | Sell |
25,214
-15,030
| -37% | -$1.27M | 0.03% | 690 |
|
|
2017
Q1 | $3.58M | Sell |
40,244
-15,260
| -27% | -$1.27M | 0.04% | 458 |
|
|
2016
Q4 | $4.11M | Sell |
55,504
-44,961
| -45% | -$3.37M | 0.04% | 323 |
|
|
2016
Q3 | $7.6M | Buy |
100,465
+27,912
| +38% | +$2.14M | 0.1% | 125 |
|
|
2016
Q2 | $5.59M | Buy |
72,553
+32,113
| +79% | +$2.53M | 0.06% | 226 |
|
|
2016
Q1 | $3.16M | Buy |
40,440
+11,260
| +39% | +$786K | 0.05% | 308 |
|
|
2015
Q4 | $1.97M | Buy |
29,180
+20,195
| +225% | +$1.41M | 0.05% | 368 |
|
|
2015
Q3 | $695K | Sell |
8,985
-25,214
| -74% | -$2.23M | 0.02% | 848 |
|
|
2015
Q2 | $3.1M | Sell |
34,199
-8,122
| -19% | -$651K | 0.06% | 299 |
|
|
2015
Q1 | $3.18M | Buy |
42,321
+34,085
| +414% | +$2.45M | 0.09% | 191 |
|
|
2014
Q4 | $604K | Buy |
+8,236
| New | +$579K | 0.03% | 599 |
|
Other funds holding HCA
Paloma Partners's HCA Position: Q2 2025 in Review
Paloma Partners sold out of HCA Healthcare (HCA) in Q2 2025, closing a stake of 1,140 shares — an estimated $394K sold.
Paloma Partners first reported a position in HCA in Q4 2014 and held it in 37 quarters. The position peaked at $13.6M in Q3 2021. 1,248 funds tracked by Wall St. Rank hold HCA as of Q2 2025.
- Paloma Partners reported no remaining HCA Healthcare position as of Q2 2025 after selling out during the quarter.
- Paloma Partners sold 1,140 HCA Healthcare shares in Q2 2025, an estimated $394K.
- Paloma Partners first reported a position in HCA Healthcare in Q4 2014 and held it in 37 quarters.
- Paloma Partners's HCA Healthcare position peaked at $13.6M in Q3 2021.
- 1,248 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2025.
Based on Paloma Partners's 13F filing for Q2 2025, filed 14 Aug 2025.